0ET Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Esperion Therapeutics Inc

Watchlist Manager

Watchlist

Price: 1.9915 EUR -18.38%

Market Cap: €215.8m

E	Esperion Therapeutics Inc SWB:0ET	US
S	Securitas AB F:S7MB	SE
	Electricite de Strasbourg SA PAR:ELEC	FR
G	GFT Technologies SE XMUN:GFT	DE
	Holcim AG F:HLBN	CH
S	Sany Heavy Equipment International Holdings Company Ltd XMUN:YXS	CN
C	CBRE Group Inc XBER:RF6	US
M	McDonald's Corp SWB:MDO	US
S	Soleno Therapeutics Inc F:6XC1	US
	C Rad AB F:24C	SE
	Koninklijke Ahold Delhaize NV F:AHOD	NL

Profitability Summary

Esperion Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

68%

Strong 3Y Average Gross Margin

69%

Gross Margin is Increasing

61% > 68%

Healthy Operating Margin

15%

Negative 3Y Average Operating Margin

-62%

Operating Margin is Increasing

-229% > 15%

Negative Net Margin

-6%

Negative 3Y Average Net Margin

-99%

Net Margin is Increasing

-295% > -6%

Negative Free Cash Flow Margin

-3%

Negative 3Y Average Free Cash Flow Margin

-69%

Free Cash Flow Margin is Increasing

-235% > -3%

Low ROE

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-70%

ROIC is Increasing

-218% > 34%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.